Cargando…
Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
IMPORTANCE: Clinical research supporting US Food and Drug Administration (FDA) drug approvals is largely conducted outside the US. OBJECTIVE: To characterize where drugs were tested for FDA approval and to determine how commonly and quickly these drugs received marketing approval in the countries wh...
Autores principales: | Miller, Jennifer E., Mello, Michelle M., Wallach, Joshua D., Gudbranson, Emily M., Bohlig, Blake, Ross, Joseph S., Gross, Cary P., Bach, Peter B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100865/ https://www.ncbi.nlm.nih.gov/pubmed/33950209 http://dx.doi.org/10.1001/jamanetworkopen.2021.7075 |
Ejemplares similares
-
Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries
por: Green, Angela K., et al.
Publicado: (2021) -
Spending by the Centers for Medicare & Medicaid Services Before and After Confirmation of Benefit for Drugs Granted US Food and Drug Administration Accelerated Approval, 2012 to 2017
por: Skydel, Joshua J., et al.
Publicado: (2022) -
Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments
por: Skydel, Joshua J., et al.
Publicado: (2019) -
Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies
por: Tay-Teo, Kiu, et al.
Publicado: (2019) -
Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021
por: Gupta, Ravi, et al.
Publicado: (2022)